Novel Probiotic Bifidobacterium longum inhibits the Inflammatory Response Induced by Gliadins in Coeliac Disease Patients
Vendor Organization : BIOPOLIS, S.L. / Spain 
Type of Organization : Small and medium size company (SME)
Type of Tech Offer : Product
Current Development Status : Working Prototype or Samples Ready for Testing
Required business relationship : Commercial agreement , License agreement
Sector : Biotechnology, Food & drink, Healthcare, Pharmaceutical
Domains of Knowledge : Life sciences
Tags : Biotechnology, microorganism, probiotics, Bifidobacterium longum, coeliac disease, gluten





